Mateos, M., Martínez-López, J., Gonzalez-Calle, V., Perez, M. S. G., Oriol, A., Jimenez, J. L., -Segura, M. R., Tamayo, R. R., Rodriguez-Otero, P., Dachs, L. R., Rubia, J. D. L., Arriba, F. D., Lakhwani, S., Bargay, J., Gonzalez, A. P., Puig, N., Romero, M. T. C., Paiva, B., Alegre, A., Barrigón, F. E., Inigo-Rodriguez, M. B., Teruel, A., Palomera, L., García-Mateo, A., Alvarez-Rivas, M., Ocio, E., Creixenti, J. B. B., Palacios, J. L., San-Miguel, J. (2025). Early rescue intervention with daratumumab, pomalidomide and dexamethasone (DPd) in high-risk smoldering myeloma (HR-SMM) patients included in the GEM-CESAR treated with carfilzomib, lenalidomide and dexamethasone (KRd)- autologous stem cell transplantation (ASCT)-krd-rd. Blood. https://doi.org/10.1182/blood-2025-371